Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.
Minowa T, Murata K, Mizue Y, Murai A, Nakatsugawa M, Sasaki K, Tokita S, Kubo T, Kanaseki T, Tsukahara T, Handa T, Sato S, Horimoto K, Kato J, Hida T, Hirohashi Y, Uhara H, Torigoe T. Minowa T, et al. Among authors: murai a. Sci Transl Med. 2024 Dec 4;16(776):eadk8832. doi: 10.1126/scitranslmed.adk8832. Epub 2024 Dec 4. Sci Transl Med. 2024. PMID: 39630887
Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes.
Minowa T, Hirohashi Y, Murata K, Sasaki K, Handa T, Nakatsugawa M, Mizue Y, Murai A, Kubo T, Kanaseki T, Tsukahara T, Iwabuchi S, Hashimoto S, Ishida-Yamamoto A, Uhara H, Torigoe T. Minowa T, et al. Among authors: murai a. J Pathol. 2023 Jul;260(3):304-316. doi: 10.1002/path.6083. Epub 2023 May 3. J Pathol. 2023. PMID: 37138382
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.
Yamada S, Miyata H, Isono M, Hori K, Yanagawa J, Murai A, Minowa T, Mizue Y, Sasaki K, Murata K, Tokita S, Nakatsugawa M, Iwabuchi S, Hashimoto S, Kubo T, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Yamada S, et al. Among authors: murai a. Cancer Immunol Immunother. 2023 Jul;72(7):2057-2065. doi: 10.1007/s00262-023-03388-5. Epub 2023 Feb 16. Cancer Immunol Immunother. 2023. PMID: 36795123 Free PMC article.
Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy.
Miyamoto S, Hirohashi Y, Morita R, Miyazaki A, Ogi K, Kanaseki T, Ide K, Shirakawa J, Tsukahara T, Murai A, Sasaya T, Koike K, Kina S, Kawano T, Goto T, Ntege EH, Shimizu Y, Torigoe T. Miyamoto S, et al. Among authors: murai a. Cancer Sci. 2023 Sep;114(9):3496-3508. doi: 10.1111/cas.15873. Epub 2023 Jun 21. Cancer Sci. 2023. PMID: 37344992 Free PMC article.
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.
Wada A, Hirohashi Y, Kutomi G, Murata K, Iwabuchi S, Mizue Y, Murai A, Kyuno D, Shima H, Minowa T, Sasaki K, Kubo T, Kanaseki T, Tsukahara T, Nakatsugawa M, Hashimoto S, Osanai M, Torigoe T, Takemasa I. Wada A, et al. Among authors: murai a. Cancer Sci. 2023 Dec;114(12):4511-4520. doi: 10.1111/cas.15986. Epub 2023 Nov 22. Cancer Sci. 2023. PMID: 37991442 Free PMC article.
Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
Shirosaki T, Kawai N, Ebihara Y, Murai A, Kubo T, Morita R, Murata K, Kanaseki T, Tsukahara T, Shichinohe T, Hirohashi Y, Hirano S, Torigoe T. Shirosaki T, et al. Among authors: murai a. Anticancer Res. 2024 May;44(5):1877-1883. doi: 10.21873/anticanres.16989. Anticancer Res. 2024. PMID: 38677758
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.
Hori K, Yamada S, Murata K, Miyata H, Mizue Y, Murai A, Minowa T, Sasaki K, Shijubou N, Kubo T, Morita R, Tokita S, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Hori K, et al. Among authors: murai a. Hum Vaccin Immunother. 2024 Dec 31;20(1):2414542. doi: 10.1080/21645515.2024.2414542. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539024 Free PMC article.
296 results